Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis

Published:2021-03 Issue:3 Volume:12 Page:e00315
ISSN:2155-384X
Container-title:Clinical and Translational Gastroenterology
language:en
Short-container-title:Clinical and Translational Gastroenterology

Author:

Bossen Lars,Vesterhus Mette,Hov Johannes R.,Färkkilä Martti,Rosenberg William M.,Møller Holger J.,Boberg Kirsten M.,Karlsen Tom H.,Grønbæk Henning

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology

Reference39 articles.

1. Primary sclerosing cholangitis;Hirschfield;The Lancet,2013

2. Primary sclerosing cholangitis: a comprehensive review;Karlsen;J Hepatol,2017

3. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis;J Hepatol,2017

4. Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process;Ponsioen;Hepatology,2016

5. Prognostic biomarkers and surrogate end points in PSC;Vesterhus;Liver Int,2016

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urinary soluble CD163 is a putative non-invasive biomarker for primary sclerosing cholangitis;Experimental and Molecular Pathology;2024-06

2. Targeting osteopontin to treat primary sclerosing cholangitis;Current Opinion in Gastroenterology;2024-01-02

3. Serum monocyte chemotactic protein 1 and soluble mannose receptor aid predictive diagnosis of pediatric sepsis;American Journal of Translational Research;2024

4. The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis;Hepatology Communications;2023-03-24

5. Noninvasive evaluation of fibrosis in adult biliary diseases;Current Opinion in Gastroenterology;2023-01-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3